Synopsis
The Center for Drug Evaluation and Research's ARC Program Releases 2026 Annual Report The Accelerating Rare disease Cures (ARC) Program has released the 2026 Annual Report: Sustaining Progress, Expanding Possibilities in Rare Disease Drug Development.
Automatically extracted from the original page. This is a short summary, not the full story, and may omit important detail.
Read the full story at FDA: drugs ↗
